Deversify Revenue and Competitors

Deversify is a Swedish research and development company offering solutions in the field of digital health. We help people understand — and improve — their own health. Our mission is to act as a good force against today's lifestyle diseases – such as obesity, diabetes, addictions and cardiovascular disease. In particular, we are targeting three of the ‘big killers': obesity, smoking and heart disease. The proportion of people who suffer from lifestyle diseases is increasing globally and we have developed three m-health tools (devices and software applications) in order to combat the these: Acetrack — A breathalyser and our prime product currently. In one exhale you can instantly see if you have started to burn fat and how much. See more at: https://getacetrack.com/en/home/ Aspirable — A breathalyser which senses if you have been smoking in the last 12 hours. An alcohol-meter but for smoking. Apicardio — Our mobile, affordable, ECG patch. ECG is unnecessarily expensive, and we want to develop a patch that is both wireless and online and available to more users. Our solution is more flexible than other ECG devices on the market since it is smaller, wireless and cheaper. Deversify was founded in 2016 by the m-Health specialists Anders Murman and Åsa Lang. Anders and Åsa have dedicated their lives to building and commercialising med-tech products to combat cancer, asthma and more – from Uppsala, Sweden to Silicon Valley CA. We at Deversify are passionate about health measurements because we want to make health status accessible to all and help you understand Your own individual health better. Knowledge is power, and self-knowledge is power over your own health. By tracing which lifestyle changes work for you, you can drastically improve your wellbeing. Deversify is here to help you understand your wellbeing holistically – inside and out, from ketones to ECG.